Article info
PDFA difficult case
Toxic cerebellar syndrome due to methotrexate
- Correspondence to Dr Olga Kinzel, Department of Neurology, Inselspital, Bern 3010, Switzerland; olga.kinzel{at}insel.ch
Citation
Toxic cerebellar syndrome due to methotrexate
Publication history
- Accepted February 22, 2015
- First published March 26, 2015.
Online issue publication
April 14, 2016
Article Versions
- Previous version (14 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era
- Erdheim-Chester disease: misdiagnosed as multiple sclerosis
- Progressive multifocal leucoencephalopathy isolated to the brainstem and cerebellum
- Mefloquine in the treatment of progressive multifocal leukoencephalopathy
- Republished: A practical approach to late-onset cerebellar ataxia: putting the disorder with lack of order into order
- Genotype-associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro-cerebellar connectivity alterations
- A practical approach to late-onset cerebellar ataxia: putting the disorder with lack of order into order
- Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis
- A case report of progressive multifocal leucoencephalopathy (PML) associated with adalimumab
- Rhomboencephalitis